Investigational Site Number : 3920006

Fukui 910-1104

0 studies enrolling now · 1 studies all time

What they study most

Chronic Rhinosinusitis With Nasal Polyps

Studies at this site

• A Phase 3 Study to Assess the Efficacy, Safety, and Tolerability of Itepekimab (Anti-IL-33 mAb) in Participants With Inadequately-controlled Chronic Rhinosinusitis With Nasal Polyps — Running, not enrolling